ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877 This issue Cite
Erratum
Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum
Ping Ji1*, Yongxin Zhou2*, Yibao Yang1*, Junlu Wu1, Hao Zhou3, Wenqiang Quan1, Junjun Sun1, Yiwen Yao1, Anquan Shang1, Chenzheng Gu1, Bingjie Zeng1, Jenni Firrman4, Weidong Xiao5, Robert Bals6, Zujun Sun1, Dong Li1 
1. Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
2. Department of Thoracic-cardiovascular Surgery, Tongji hospital,Tongji University School of Medicine, Shanghai 200065, China.
3. Department of Pharmacy, Putuo People's Hospital, Shanghai 200060, China.
4. Dairy and Functional Foods Research Unit, Eastern Regional Research Center, Agriculture Research Service, United States Department of Agriculture, Wyndmoor, PA 19038, USA.
5. Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, PA 19140, USA.
6. Department of Internal Medicine V-Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg 66424, Germany.
*The authors contributed equally to this work.
Citation:
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877. https://www.thno.org/v13p3640.htm
Other stylesCorrected-article in Theranostics, Volume 9, 2209
We apologize that the original version of the above article contains errors that need to be corrected. The representative immunostaining images of Ki67 in the 10 ug LL-37 and 10ug LL-37 +XAV939 groups in Figure 6A were mis-pasted when choosing representative images from the image data. We confirm that these corrections made in this erratum do not affect the original conclusions. All the authors of the paper have agreed to this correction. The corrected Figure 6A appears below.
Figure 6
(A) Immunohistochemical analysis of the expression of unphosphorylated β-catenin, PCNA, and Ki67 in C57BL/6 mice inoculated with 2×105 LLC cells with indicated treatments. Scale bar, 50 μm.
Author contact
Corresponding authors: Zujun Sun, email: 14111010030edu.cn; and Dong Li, email: lidongedu.cn
Published 2023-6-21
Citation styles
APA
Ji, P., Zhou, Y., Yang, Y., Wu, J., Zhou, H., Quan, W., Sun, J., Yao, Y., Shang, A., Gu, C., Zeng, B., Firrman, J., Xiao, W., Bals, R., Sun, Z., Li, D. (2023). Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics, 13(11), 3640. https://doi.org/10.7150/thno.82877.
ACS
Ji, P.; Zhou, Y.; Yang, Y.; Wu, J.; Zhou, H.; Quan, W.; Sun, J.; Yao, Y.; Shang, A.; Gu, C.; Zeng, B.; Firrman, J.; Xiao, W.; Bals, R.; Sun, Z.; Li, D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023, 13 (11), 3640. DOI: 10.7150/thno.82877.
NLM
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877. https://www.thno.org/v13p3640.htm
CSE
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. 2023. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics. 13(11):3640.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.